Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Total Current Liabilities (2020 - 2026)

Journey Medical filings provide 6 years of Total Current Liabilities readings, the most recent being $37.4 million for Q4 2025.

  • On a quarterly basis, Total Current Liabilities rose 6.44% to $37.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $37.4 million, a 6.44% increase, with the full-year FY2025 number at $37.4 million, up 6.44% from a year prior.
  • Total Current Liabilities hit $37.4 million in Q4 2025 for Journey Medical, down from $39.7 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $76.9 million in Q1 2023 to a low of $33.3 million in Q3 2024.
  • Median Total Current Liabilities over the past 5 years was $45.2 million (2023), compared with a mean of $49.7 million.
  • Biggest five-year swings in Total Current Liabilities: surged 83.93% in 2021 and later tumbled 49.93% in 2024.
  • Journey Medical's Total Current Liabilities stood at $51.6 million in 2021, then increased by 29.48% to $66.8 million in 2022, then plummeted by 37.35% to $41.9 million in 2023, then fell by 15.99% to $35.2 million in 2024, then increased by 6.44% to $37.4 million in 2025.
  • The last three reported values for Total Current Liabilities were $37.4 million (Q4 2025), $39.7 million (Q3 2025), and $40.5 million (Q2 2025) per Business Quant data.